Pitolisant Receives Approval in China for Narcolepsy Treatment

The Chinese National Medical Products Administration has approved Rarestone Group’s pitolisant (Wakix) for the treatment of excessive daytime sleepiness or cataplexy in adult patients with narcolepsy.  In China, pitolisant is the first approved innovative drug for narcolepsy and the only non-scheduled drug with narcolepsy indication. Pitolisant is a selective histamine 3 receptor antagonist/inverse agonist, which…

Read More